Invention Grant
- Patent Title: Methods and drugs targeting Eva1 or Ceacam1 gene expression for treatment and diagnosing of glioma
-
Application No.: US13877023Application Date: 2011-09-29
-
Publication No.: US09675693B2Publication Date: 2017-06-13
- Inventor: Toru Kondo
- Applicant: Toru Kondo
- Applicant Address: JP Wako-shi, Saitama
- Assignee: RIKEN
- Current Assignee: RIKEN
- Current Assignee Address: JP Wako-shi, Saitama
- Agency: Sughrue Mion, PLLC
- Priority: JP2010-222832 20100930; JP2011-144115 20110629
- International Application: PCT/JP2011/072428 WO 20110929
- International Announcement: WO2012/043747 WO 20120405
- Main IPC: A61K39/44
- IPC: A61K39/44 ; A61K39/395 ; C07K16/30 ; A61K31/542 ; A61K31/7105 ; G01N33/68 ; C07K16/28 ; A61K39/00
Abstract:
An object is to provide glioma treatment and testing methods, and a method for delivering a desired substance to a glioma, all of which target a molecule specifically expressed in a glioma, as well as drugs and so forth used in these methods. It has been found out that targeting Eva1 or Ceacam1 enables glioma treatment and testing, and delivering of a desired substance to a glioma.
Public/Granted literature
Information query
